Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 3—March 2007
Letter

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027

Denise Drudy*Comments to Author , Lorraine Kyne†, Rebecca O’Mahony*, and Séamus Fanning*
Author affiliations: *University College Dublin, Dublin, Ireland; †Mater Misericordiae University Hospital, Dublin, Ireland;

Main Article

Table

Characterization of representative isolates, Ireland, 2006

Isolate Toxigenic status Ribotype Fluoroquinolone MIC μg/mL
Amino acid substitution
Ciprofloxacin Ofloxacin Levofloxacin Gatifloxacin Moxifloxacin
1470* A-B+ 017 >32 >32 3 0.38 0.25 Thr 82
VPI10463* A+B+ D >32 >32 3 0.38 0.25 Thr 82
CD 196* A+B+ 027 >32 >32 3 0.38 0.25 Thr 82
M216† A+B+ 027 >32 >32 >32 >32 >32 Thr-82-Iso
C2191† A+B+ 027 >32 >32 >32 >32 >32 Thr-82-Iso
V6-13† A+B+ 027 >32 >32 >32 >32 >32 Thr-82-Iso
V6-15† A+B+ 027 >32 >32 >32 >32 >32 Thr-82-Iso
V6-20† A+B+ 027 >32 >32 >32 >32 >3 Thr-82-Iso

*Control isolates VPI-10463, 1470 CD196.
†Clinical 027 isolates from 3 different institutions investigated in this study.

Main Article

Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external